These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10439830)

  • 1. New ethical obligations accompany new HIV drugs, conference told.
    Silversides A
    CMAJ; 1999 Jul; 161(2):187. PubMed ID: 10439830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress toward a once daily regimen. (HA)ART--the art of antiretroviral therapy].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():78-9. PubMed ID: 11373790
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interview with Prof. Reinhold E. Schmidt. Important selection criteria: tolerance and simplicity]].
    Schmidt RE
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():84-5. PubMed ID: 16385889
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quality of life as the focus of modern anti-HIV treatment. More compact regimens for therapy success].
    MMW Fortschr Med; 2001 Sep; 143(35-36):58-9. PubMed ID: 11584536
    [No Abstract]   [Full Text] [Related]  

  • 5. Merck pushes the envelope with once-daily indinavir.
    TreatmentUpdate; 2001; 12(12):8. PubMed ID: 11570096
    [No Abstract]   [Full Text] [Related]  

  • 6. [HIV management requires strategic planning. Optimal sequencing of protease inhibitors].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():21-4. PubMed ID: 11373770
    [No Abstract]   [Full Text] [Related]  

  • 7. [HIV therapy in childhood. Also once daily lopinavir/r is effective].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():55. PubMed ID: 16385877
    [No Abstract]   [Full Text] [Related]  

  • 8. A chat with HIV specialists: the Geneva report.
    Newsline People AIDS Coalit N Y; 1998 Sep; ():12-7. PubMed ID: 11367483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Simply convincing. New fixed combination for HIV therapy].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():20-3. PubMed ID: 16385865
    [No Abstract]   [Full Text] [Related]  

  • 10. [Individualized therapy with fosamprenavir/r. A PI suitable in liver problems].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():60-1. PubMed ID: 19031566
    [No Abstract]   [Full Text] [Related]  

  • 11. [Non-nucleoside reverse transcriptase inhibitors. First line therapy].
    MMW Fortschr Med; 2000; 142(3 Suppl):34-5. PubMed ID: 10893964
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors associated with incomplete virological response to highly active antiretroviral therapy.
    Welch K; Morse A; Clark R; Ogbuokiri T
    Clin Infect Dis; 2000 Feb; 30(2):407-8. PubMed ID: 10671360
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV medical advances explored at retrovirus conference.
    Dorenbaum A; Miserez AR
    AIDS Policy Law; 2001 May; 16(10):4. PubMed ID: 11569980
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiviral therapy: how simple can you get?
    Gilden D
    GMHC Treat Issues; 1998 Nov; 12(11):3-7. PubMed ID: 11365906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should you enroll in a clinical trial?
    Linde M
    Posit Living; 2002; 11(5):37-42. PubMed ID: 12422826
    [No Abstract]   [Full Text] [Related]  

  • 16. [Switch strategy: replacing the protease inhibitor. Quality of life improves].
    MMW Fortschr Med; 2000; 142(3 Suppl):37. PubMed ID: 11012292
    [No Abstract]   [Full Text] [Related]  

  • 17. The psychology of compliance.
    Condor B
    Posit Aware; 1997; 8(2):18-20. PubMed ID: 11364453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard treatments for HIV, Spring 1997.
    Smith D
    AIDS Treat News; 1997 Apr; (No 269):4-5. PubMed ID: 11364255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possible cardiovascular complications. What leads to "switching"].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():82. PubMed ID: 12043091
    [No Abstract]   [Full Text] [Related]  

  • 20. [New antiretroviral drugs. Improved pharmacokinetics and simpler dose schedules].
    Arastéh K; Müller M
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():14-7. PubMed ID: 11373768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.